Skip to main content

Research Repository

Advanced Search

Comparative pathology of dog and human prostate cancer

Ryman-Tubb, Toby; Lothion-Roy, Jennifer H.; Metzler, Veronika M.; Harris, Anna E.; Robinson, Brian D.; Rizvanov, Albert A.; Jeyapalan, Jennie N.; James, Victoria H.; England, Gary; Rutland, Catrin S.; Persson, Jenny L.; Kenner, Lukas; Rubin, Mark A.; Mongan, Nigel P.; de Brot, Simone

Comparative pathology of dog and human prostate cancer Thumbnail


Authors

Toby Ryman-Tubb

Jennifer H. Lothion-Roy

Veronika M. Metzler

Anna E. Harris

Brian D. Robinson

Albert A. Rizvanov

VICTORIA JAMES VICTORIA.JAMES@NOTTINGHAM.AC.UK
Professor of Molecular Biology

GARY ENGLAND gary.england@nottingham.ac.uk
Foundation Dean & Prof Comparative Veterinary Reproduction

CATRIN RUTLAND CATRIN.RUTLAND@NOTTINGHAM.AC.UK
Professor of Molecular Medicine

Jenny L. Persson

Lukas Kenner

Mark A. Rubin

NIGEL MONGAN nigel.mongan@nottingham.ac.uk
Associate Pro-Vice Chancellorglobal Engagement

Simone de Brot



Abstract

Though relatively rare in dogs, prostate cancer (PCa) is the most common non-cutaneous cancer in men. Human and canine prostate glands share many functional, anatomical and physiological features. Due to these similarities, canine PCa has been proposed as a model for PCa in men. PCa is typically androgen-dependent at diagnosis in men and for this reason, androgen deprivation therapies (ADT) are important treatments for advanced PCa in men. In contrast, there is some evidence that PCa is diagnosed more commonly in castrate dogs, at which point, limited therapeutic options are available. In men, a major limitation of current ADT is that progression to a lethal and incurable form of PCa, termed castrate-resistant prostate cancer (CRPC), is common. There is, therefore, an urgent need for a better understanding of the mechanism of PCa initiation and progression to CRPC to enable the development of novel therapeutic approaches. This review focuses on the functional, physiological, endocrine and histopathological similarities and differences in the prostate gland of these species. In particular, we focus on common physiological roles for androgen signalling in the prostate of men and dogs, we review the short- and longer-term effects of castration on PCa incidence and progression in the dog and relate how this knowledge may be relevant to understanding the mechanisms of CRPC in men.

Citation

Ryman-Tubb, T., Lothion-Roy, J. H., Metzler, V. M., Harris, A. E., Robinson, B. D., Rizvanov, A. A., …de Brot, S. (2022). Comparative pathology of dog and human prostate cancer. Veterinary Medicine and Science, 8(1), 110-120. https://doi.org/10.1002/vms3.642

Journal Article Type Review
Acceptance Date Sep 14, 2021
Online Publication Date Oct 10, 2021
Publication Date Jan 1, 2022
Deposit Date Oct 10, 2021
Publicly Available Date Oct 15, 2021
Journal Veterinary Medicine and Science
Electronic ISSN 2053-1095
Publisher Wiley Open Access
Peer Reviewed Peer Reviewed
Volume 8
Issue 1
Pages 110-120
DOI https://doi.org/10.1002/vms3.642
Public URL https://nottingham-repository.worktribe.com/output/6453272
Publisher URL https://onlinelibrary.wiley.com/doi/10.1002/vms3.642

Files





You might also like



Downloadable Citations